Jan Pohl Selected Research

Jan Pohl Research Topics

Disease

20	Infections 01/2021 - 06/2003
6	Inflammation (Inflammations) 11/2022 - 11/2007
5	Neoplasms (Cancer) 04/2008 - 09/2006
3	Human Influenza (Influenza) 01/2020 - 01/2011
2	Atherosclerosis 11/2022 - 11/2007
2	Malaria 01/2021 - 10/2005
2	Fibrosis (Cirrhosis) 01/2018 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2015 - 06/2005
2	Cystic Fibrosis (Mucoviscidosis) 12/2007 - 12/2002
1	COVID-19 12/2020
1	Prodromal Symptoms 12/2018
1	Disease Susceptibility (Diathesis) 10/2017
1	Necrosis 09/2017
1	Bacterial Infections (Bacterial Infection) 09/2017
1	Chlamydia Infections 01/2017
1	Respiratory Syncytial Virus Infections 01/2016
1	Starvation 12/2015
1	Fever (Fevers) 05/2015
1	Cough 05/2015
1	Infertility (Sterility) 01/2015
1	Carcinogenesis 01/2015
1	Toxocariasis 01/2015
1	Septic Shock (Toxic Shock Syndrome) 06/2014
1	Sepsis (Septicemia) 06/2014
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Tuberculosis (Tuberculoses) 01/2013
1	Meningococcal Infections 10/2010
1	Type I Syndactyly 09/2010
1	Pneumococcal Infections 08/2010
1	Obesity 01/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2005
13	Peptides (Polypeptides)IBA 01/2020 - 11/2002
7	CathelicidinsIBA 01/2020 - 10/2010
6	Antiviral Agents (Antivirals)IBA 01/2020 - 10/2009
3	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 06/2003
3	AntigensIBA 01/2021 - 11/2002
3	AntibodiesIBA 01/2021 - 12/2018
3	EpitopesIBA 01/2021 - 10/2005
3	Antimicrobial Cationic PeptidesIBA 10/2017 - 01/2011
3	ProteomeIBA 12/2015 - 12/2006
3	Biomarkers (Surrogate Marker)IBA 02/2007 - 06/2005
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2022 - 01/2010
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 04/2008
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2015
2	Colistin (Coly-Mycin)FDA Link 01/2016 - 05/2013
2	Sulfhydryl Compounds (Thiols)IBA 12/2015 - 11/2007
2	Amino Acids FDA Link 12/2015 - 03/2006
2	Cystine (L-Cystine)IBA 09/2010 - 01/2010
2	Biological ProductsIBA 05/2007 - 10/2005
1	Serine Proteases (Serine Protease)IBA 11/2022
1	Kallikreins (Kallikrein)IBA 11/2022
1	Apolipoproteins E (ApoE)IBA 11/2022
1	Immunoglobulin IsotypesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	TARPIBA 01/2019
1	Myosin Type IIIBA 01/2019
1	Connective Tissue Growth FactorIBA 01/2018
1	CollagenIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	OligonucleotidesIBA 01/2018
1	protegrin-1IBA 09/2017
1	Inositol (Myoinositol)IBA 01/2017
1	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	ChemokinesIBA 01/2016
1	leupeptinIBA 12/2015
1	EnzymesIBA 05/2015
1	CaspasesIBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	mouse MIRN29 microRNAIBA 01/2015
1	Caspase InhibitorsIBA 01/2015
1	GalactosamineIBA 06/2014
1	EndotoxinsIBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2013
1	Subunit VaccinesIBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013
1	Complementary RNA (cRNA)IBA 01/2012
1	InterferonsIBA 01/2012
1	3' Untranslated Regions (3' UTR)IBA 01/2012
1	LigandsIBA 01/2012
1	Complement System Proteins (Complement)IBA 01/2012
1	5' Untranslated Regions (5' UTR)IBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2011
1	prostatic acid phosphataseIBA 01/2011
1	DefensinsIBA 01/2011
1	Antimicrobial PeptidesIBA 01/2011
1	VaccinesIBA 10/2010
1	Virulence Factors (Pathogenicity Factors)IBA 10/2010
1	Polysaccharides (Glycans)IBA 10/2010
1	DisulfidesIBA 09/2010
1	Recombinant ProteinsIBA 09/2010
1	MacrolidesIBA 08/2010

Therapy/Procedure

4	Therapeutics 09/2017 - 04/2008